Alex Bullock
0000-0001-6757-0436
Oxford University
5 papers found
Refreshing results…
Discovery of Conformationally Constrained ALK2 Inhibitors
Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake Assays
Target 2035 – an update on private sector contributions
Leveraging an Open Science Drug Discovery Model to Develop CNS Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
Missing publications? Search for publications with a matching author name.